27.80
-0.23 (-0.82%)
| Penutupan Terdahulu | 28.03 |
| Buka | 28.62 |
| Jumlah Dagangan | 559,916 |
| Purata Dagangan (3B) | 464,780 |
| Modal Pasaran | 975,611,520 |
| Harga / Buku (P/B) | 3.82 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Aug 2026 |
| EPS Cair (TTM) | -2.30 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 19.01% |
| Nisbah Semasa (MRQ) | 22.53 |
| Aliran Tunai Operasi (OCF TTM) | -53.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -39.36 M |
| Pulangan Atas Aset (ROA TTM) | -22.88% |
| Pulangan Atas Ekuiti (ROE TTM) | -38.04% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Alto Neuroscience, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 4.0 |
| Purata | 1.17 |
|
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals’ neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 7.48% |
| % Dimiliki oleh Institusi | 77.52% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Alpha Wave Global, Lp | 31 Mar 2026 | 3,707,757 |
| Commodore Capital Lp | 31 Mar 2026 | 2,723,196 |
| Vestal Point Capital, Lp | 31 Mar 2026 | 2,064,075 |
| Spruce Street Capital Lp | 31 Mar 2026 | 1,325,210 |
| Vivo Capital, Llc | 31 Mar 2026 | 1,035,551 |
| 72 Investment Holdings, Llc | 31 Mar 2026 | 667,778 |
| Ikarian Capital, Llc | 31 Mar 2026 | 515,000 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |